Fig 1.
Kaplan-Meier curves show overall survival (OS) and progression-free survival (PFS) in all patients.
The 1- and 2-year OS rates for all patients were 61.6% and 48.6%, respectively (a). The 1- and 2-year PFS rates were 25.0% and 16.7%, respectively (b).
Fig 2.
Receiver operating characteristic curve analysis of pretreatment serum albumin.
The maximum area under the curve (AUC) was 0.729 for pretreatment serum albumin.
Table 1.
Patients’ clinical characteristics are stratified by albumin-low and albumin-high groups.
Table 2.
Results of the Cox regression models for overall survival and progression-free survival.
Fig 3.
Kaplan-Meier curves show overall survival (OS) and progression-free survival (PFS) stratified by pretreatment serum albumin.
The 1-year OS rate in the albumin-low group (―) was 26.1%, and that in the albumin-high group (----) was 77.4% (p<0.05). The 1-year PFS rate in the albumin-low group (―) was 25.0%, and that in the albumin-high group (----) was 24.4% (p = 0.507).